Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows Revision: v3.6.5, replacing v3.6.4. This indicates a backend or CMS update rather than a change to study details or visible content.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now states that recruitment is closed with the note 'No longer looking for participants', and associated recruitment prompts and contact details have been removed. This reflects that the study is not actively enrolling at this time.SummaryDifference2%

- Check27 days agoChange DetectedThe page now displays 'Bladder cancer' and a related topics section linking to MedlinePlus Genetics, providing disease context and educational resources alongside the study information.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page shows Revision: v3.6.4 instead of v3.6.3, representing a deployment update to the site; no substantive study-content changes are reflected.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page loses the bladder cancer label and related topic sections, including MedlinePlus Genetics. This reduces navigational links to background topics on the study page.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, indicating a system/content update. It does not change the study information or user-facing content.SummaryDifference0.0%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.